Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy.
about
Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsMolecular testing in lung cancer in the era of precision medicineSurgery in 2013 and beyondPredictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)High Expression of Rab-like 3 (Rabl3) is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8/9/10-Mediated AutophagyPIAS3 expression in squamous cell lung cancer is low and predicts overall survival.Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas.New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib.FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.Genomics of squamous cell lung cancerThe new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assaysPrognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.Stage and tissue-specific prognostic impact of miR-182 in NSCLC.Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.The evolving role of the pathologist in the management of lung cancer.Integrated analyses of copy number variations and gene differential expression in lung squamous-cell carcinomaExpression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lungNext-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection.The impact of genomic changes on treatment of lung cancer.Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway.Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer.Druggable targets of squamous cell lung cancer.Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy.Discoidin domain receptor 2 signaling networks and therapy in lung cancer.Emerging drugs for squamous cell lung cancer.Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.Immunotherapy for lung cancer: for whom the bell tolls?Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.
P2860
Q26741318-38A15300-222A-407E-B16D-B8DD0E05BABBQ26824599-B58CA8EA-5BD6-475E-B13B-648C55D8DDD8Q26863046-9A211D6F-180C-4ADF-A2FE-2444213F5EFFQ27009492-C18AEC9E-8060-482D-A08C-D45930187330Q28829201-BD538CCD-06F1-47B2-89D8-8513109D7EE4Q30405870-863A3AE5-AC9D-4343-AEE0-53A1210F5DA8Q33646227-31FB3B98-61B7-4F38-B88F-040D36C99A0DQ33704088-85EBC43A-86EA-4CAF-87A7-7351817AF766Q33742954-184DA604-C17E-4B0C-8FC3-BC77D98A34B0Q33763006-0467949E-5DDE-4CAC-BF6B-91DEA94E01FDQ33777454-A7C20AE2-F606-4632-A738-D48F6F4241FBQ34404266-E2171E9F-6982-49E1-9D8E-3C3A5EAFEC2FQ34460043-E8D7F50E-0EC6-47D0-8832-4BE1897988E8Q34775815-D195D54E-9457-4AFB-B9CC-CDB6AA2D8B82Q35103842-CB7581BA-0AD0-45E6-9778-90C4B1579429Q35144952-F6BCA6C8-A5ED-4DC9-BC96-F0BACAAE5A32Q35156742-206BD811-D95A-4249-92EF-A189D40B9483Q35680083-0F3ACCE2-C798-4318-9058-09E38B91272DQ35951079-E5A0A9BC-E56C-4BCD-A5B2-4C813B7954A6Q35987044-DF0011E3-09A8-40B2-8B9F-E43908C3CC63Q36262168-C67CBFB6-6A16-40B1-97C6-0D0CF3F57C0BQ36274943-654188DD-0C90-47EA-80A5-111A68D45950Q36303134-FC6FD44E-BC95-4BD2-82EA-3B0CBEFB85A8Q36389868-8F4755BE-556E-4B23-AF6A-C8C836AB879CQ36546997-7BB26C83-4541-4B15-A8A6-47E00225090CQ36594244-9971287F-F829-4424-AB3D-5F793F0A27A5Q36673780-E4FE6EAD-014B-4BCA-9337-D57ADB0BB076Q37182254-3B724B6A-3133-4AC7-8EEA-429B4F4C03D7Q37304354-3BB6D8AB-BDBE-468E-B923-FC6B1F931305Q37311353-3B6F0619-EA26-4718-8C55-841562C832DDQ37703388-76B37F07-7EE8-4D00-8A3B-C20EA84837AFQ37738412-BC3DB896-53C4-4830-8861-5E0CC7362536Q38160089-77BDADD6-C463-4703-9E04-240F1EAB99C0Q38177792-C49E6F16-A264-471A-969B-15BAEB5F8F67Q38205723-8463909B-F5AB-4AFF-81EF-40F05DEDCF99Q38211796-B82DF49D-3824-4CCD-BE45-0EC3A6F2AEECQ38306880-506B90F5-ABE6-4BBF-ACC1-376949765AD3Q38309344-D7B49504-181E-4045-A19A-EECF14B8BB57Q38367414-868D3093-ECFD-4D3E-8784-CC88E8FD816BQ38390024-808623FB-59DB-4811-B4C5-FD49F85D99A6
P2860
Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Squamous-cell carcinomas of th ...... e promise of targeted therapy.
@en
type
label
Squamous-cell carcinomas of th ...... e promise of targeted therapy.
@en
prefLabel
Squamous-cell carcinomas of th ...... e promise of targeted therapy.
@en
P2093
P1433
P1476
Squamous-cell carcinomas of th ...... e promise of targeted therapy.
@en
P2093
Alexander Drilon
Natasha Rekhtman
P304
P356
10.1016/S1470-2045(12)70291-7
P50
P577
2012-10-01T00:00:00Z